Although board certification is not currently required in the field of neuropsychology, the number of board-certified neuropsychologists is rapidly...
27| Pediatric Traumatic Brain Injury – With Dr. Keith Yeates
We discussed INS leadership and research productivity with Keith Yeates, Ph.D., ABPP-CN, in a previous episode (click here to...
26| Neuropsych Essentials: Commentary on Clinical Report Writing
Last episode we spoke to Jacobus Donders, Ph.D., ABPP (CN, RP) about neuropsychological report writing (click here to listen...
25| Neuropsych Essentials: Enhancing the Quality and Efficiency of Our Clinical Reports – With Dr. Jacobus Donders
Writing effective reports allows neuropsychologists to share important insights and recommendations gleaned from a neuropsychological evaluation. Although the format...
24| Professional Development: Leadership, Training, and Supervision – With Dr. Neil Pliskin
We discussed the cognitive and emotional effects of electrical injury with Neil Pliskin, Ph.D., ABPP-CN, in a previous episode...
23| Pediatric Epilepsy – With Dr. Nancy Nussbaum (Part 2)
Today we bring you the conclusion of our conversation with epilepsy expert Nancy Nussbaum, Ph.D., ABPP-CN (see the show...
22| Pediatric Epilepsy – With Dr. Nancy Nussbaum (Part 1)
Epilepsy is a broad term used to describe various neurologic conditions that cause seizures. According to the Centers for...
21| Cultural Neuropsychology: Embracing the Mosaic – With Dr. Monica Rivera Mindt
Clinical neuropsychologists are currently using instruments that are derived predominantly from monolingual, monocultural, and homogenous populations. According to U.S....
20| The Interplay Between Cerebrovascular Disease and Alzheimer’s Disease – With Dr. Adam Brickman
Adam Brickman, Ph.D., returns to discuss the involvement of white matter disease in Alzheimer’s disease progression and clinical presentation....
19| Redefining Alzheimer’s Disease: Does Cognition Matter? – With Dr. Adam Brickman
The estimated annual cost of healthcare for individuals living with Alzheimer’s disease (AD) or other dementias is almost $300...